The U.S. Food and Drug Administration has approved Inlexzo (gemcitabine intravesical system) for the treatment of patients with certain types of bladder cancer.
This article was originally published on MedicalXpress.com
FDA approves Inlexzo for bladder cancer
You may also be interested in:
The Latest
Why you should stop buying vitamins and get more sleep instead
Almost half of all Canadians regularly take at least one nutritional supplement such as vitamins, minerals, fibre supplements, antacids and fish oils. Many of these individuals are healthy and hoping to improve general well-being or prevent chronic […]
The Latest
The Key to a Strong Relationship? Communication
Effective communication is the foundation of any strong, healthy relationship. This article will explore the key elements required to build better communication between partners. We’ll cover the importance of active listening, using empathy and understanding […]
The Latest
Setting Boundaries: Nurturing a Healthy Partnership
What Are Boundaries? As the word portrays, boundaries in a relationship help each person establish expectations with their partner. Boundaries can help you communicate what you are comfortable with and what you are willing to […]
Read More:
-
A major study of laser correction for short-sightedness shows that the procedure is as safe and effective in older teenagers as it is in adults, [...]
-
A landmark international study has revealed that gestational diabetes (GDM) during pregnancy is strongly associated with declines in intellectual function for mothers and a higher [...]
-
For pregnant women, ultrasounds are an informative (and sometimes necessary) procedure. They typically produce two-dimensional black-and-white scans of fetuses that can reveal key insights, including [...]
